- coronavirusCOMMERCIAL & COMPANY LAW

Episode 11 - COVID-19 Webcast - Where Are We Now? Legal & Regulatory Update
23/07/2020

This is the 11th episode of our COVID-19 webcast series. In this new episode, Mark Shaw gives a quick run-down of where we are in terms of financial services regulation, corporate law and tax. A look back over the various responses to the COVID-19 pandemic to see which are still applicable while we are in this period between the initial wave and our ultimate return to normality.

Read more

EP10 - COVID-19: Recommendations of the European Systemic Risk Board by Mark Shaw
11/06/2020

In this 10th episode, Partner Mark Shaw talks about some recommendations of the European Systemic Risk Board in the wake of the COVID-19 pandemic. They focus on real estate and debt funds, but they are flagging issues relevant to all asset managers, so the recommendations are worth considering in a broader context.

Read more

Episode 9 - COVID-19 Webcast - Focus on Market Abuse During the COVID-19 Pandemic
25/05/2020

This is the ninth episode of our COVID-19 webcast series. In this episode Partner Mark Shaw wants to talk more about market abuse during the COVID-19 pandemic. While, on the whole, markets are very much down as a result of COVID-19, there are a number of companies in the biotech sector looking at vaccines against the SARS-CoV-2 virus and cures for COVID-19 that have the potential to make investors extremely rich. As such, there has probably never been a greater incentive to commit market abuse.

Read more

Special serie COVID-19 - n°9 Covid-19 - A comeback of earn-outs in M&A deals?
19/05/2020

In the context of the COVID-19 outbreak, most companies are currently facing unprecedented legal issues within their organisations. As a result, they have to adapt significantly their way of working to go through this unique time in the best possible and efficient manner. 

Read more

Approval of annual accounts during state of emergency
18/05/2020

The aim of the law is to extend the filing and publication deadlines for annual accounts, consolidated accounts and related reports as well as the holding of annual general meetings, in order to avoid exposing company managers and directors to liability and sanctions that are disproportionate given the exceptional circumstances

Read more

Wildgen Webcast - Company Groups in Times of Financial Distress: Introduction
18/05/2020

Is your group of companies faced with challenges in these difficult times? Dr. Thomas Biermeyer, specialised in corporate law and restructuring, launched a series of webcasts on the topic of company groups in times of financial distress.

Read more

Special serie COVID-19 - n°8 How to deal with corporate law issues?
14/05/2020

In the context of the COVID-19 outbreak, most companies are currently facing unprecedented legal issues within their organisations. As a result, they have to adapt significantly their way of working to go through this unique time in the best possible and efficient manner

Read more

DAC6 and CRS deadlines extended
13/05/2020

On 8 May 2020, the European Commission released a directive proposal amending the EU Directive on Administrative Cooperation to address the urgent need for deferring certain time limits for the filing and exchange of information in the field of taxation due to the COVID-19 pandemic

Read more

DAC6 and CRS deadlines extended
13/05/2020

On 8 May 2020, the European Commission released a directive proposal amending the EU Directive on Administrative Cooperation to address the urgent need for deferring certain time limits for the filing and exchange of information in the field of taxation due to the COVID-19 pandemic

Read more

COVID-19: Accounting obligations and reports – Regulatory aspects
08/05/2020

On 7 May 2020, the Luxembourg Parliament passed the draft law n°7540 which relates to the extension of certain deadlines relating to accounting obligations of entities of the financial sector, including, inter alia, SICARs, SIFs and UCIs, in order to take into account the exceptional circumstances caused by COVID-19 (the “Law n°7540”).

Read more